Maverix Medical Company Research Report
Company Overview
Name: Maverix Medical
Mission: Maverix Medical is committed to revolutionizing the diagnosis and treatment of lung cancer with a mission to improve outcomes and save lives. The company aims to leverage cutting-edge technologies and innovative solutions in lung cancer care to empower clinicians with precise diagnostic tools and personalized treatments.
Founded and Founders: No information is available
Key People:
- Duke Rohlen - Executive Chairman
- Doug Koo - Chief Financial Officer (CFO)
- Aftab Kherani, MD - Chief Medical Officer (CMO), Ajax Health
- David Mallery - CEO, Diagnostics
- Scott Morris - Chief Scientific Officer (CSO), Diagnostics
- Jeremy Durack, MD - Chief Medical Officer (CMO)
- Jocelyn Jackson - Vice President of Finance, Ajax Health
Location: 650 Live Oak Ave, Suite 100, Menlo Park, CA 94025
Number of Employees: No information is available
Revenue: No information is available
Specialization: Maverix Medical is recognized for its concentration on lung cancer diagnostics and treatment. It is particularly focused on deploying a wide array of technologies ranging from screening and diagnostics to therapeutics and palliation.
Products
Product Portfolio:
1. Screening
2. Diagnostics
3. Therapeutics
4. Palliation
High-Level Description and Key Features:
- Maverix Medical products and services are centered around the diagnosis and treatment of lung cancer, aiming to provide innovative and accurate diagnostic and therapeutic techniques. Specific high-level descriptions and key features of individual products are not detailed.
Recent Developments
- Maverix Medical was established as a medtech platform focused on lung cancer, managed by Ajax Health with collaboration from KKR and Hologic, Inc.
- Name of the platform: Maverix Medical, combining efforts with Ajax portfolio company Serpex Medical to develop and acquire new technologies in lung cancer.
- Recent studies like the "Bronchoscopic Evaluation of a Steerable Needle for Simulated Tumor Targets in the Lung Periphery" and the feasibility in cadaveric models highlight advancements in steerable instrumentation for precise tumor targeting.
New Products Launches: No information is available.
New Features Added: No specific information is available on new features added to existing products.
Partnerships and Collaborations:
- Hologic, Inc., a prominent women’s health and medical technology company, in collaboration with investment firm KKR, alongside Ajax Health, is involved in managing and developing the Maverix Medical platform.
Conclusion
Maverix Medical positions itself as a forefront innovator focusing on lung cancer treatment and diagnosis through strategic partnerships with leading healthcare companies and research institutions. With its dedication to advancing lung cancer care, Maverix Medical strives to save lives and improve patient outcomes through its specialized diagnostic and treatment solutions.
_No additional commentary available as per the request._
